Abstract
Aberrant vascular smooth muscle cell (VSMCs) proliferation involves in the development of atherosclerosis. It reported that Long noncoding BRAF-activated noncoding RNA (BANCR) and miR-34c played opposite roles in the regulation of the proliferation of VSMCs, indicating that there might be a potential interaction between them. This study was to investigate the relationship between BANCR and miR-34c in atherosclerosis. Blood (5 ml) was obtained from 56 patients with atherosclerosis and 56 healthy volunteers after they were fasted overnight, and plasma was extracted from the blood. Human Aortic Smooth Muscle Cells (HASMCs) were used to perform in vitro cell experiments. RT-qPCR was performed to measure the expression of BANCR and miR-34c in plasma and HASMCs. Dual luciferase reporter assay detected the interaction between BANCR and miR-34c. CCK-8 assay was used to assess the effects of BANCR and miR-34c overexpression on the proliferation of HASMCs. Western blotting was used to assess the effects of BANCR and miR-34c overexpression on the protein expression of HMGB1, TNF-ɑ and Bcl-2. In this study, we found that BANCR was upregulated, while miR-34c was downregulated in atherosclerosis. Bioinformatics analysis showed that BANCR and miR-34c could directly interact with each other. Moreover, overexpression of BANCR could decrease the expression of miR-34c in HASMCs, but overexpression of miR-34c could not affect the expression of BANCR. Furthermore, overexpression of BACNR increased miR-34c methylation, and knockdown of endogenous BANCR decreased miR-34c methylation. In addition, overexpression of BANCR reduced the effects of miR-34c on HASMCs proliferation and reversed the effects of miR-34c on HMGB1, TNF-ɑ and Bcl-2 expression. BANCR overexpression could induce HASMCs proliferation by downregulating the miR-34c methylation. Therefore given BANCR upregulation in atherosclerosis, its expression may be considered as a novel and useful biomarker for atherosclerosis prevention and prognosis. However considering the possible effects of other underlying diseases on both BANCR expression and miR-34c in atherosclerosis, further investigation is suggested for future research.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are not publicly available due research design, but are available from the corresponding author on reasonable request.
References
Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17(11):1410–1422. https://doi.org/10.1038/nm.2538
Long X, You G, Wu Q, Zhou Y, Xiao Y, Yu F, Deng S, Mo R, Song F, Huang J, Tian M (2020) HomeoboxC6 affects the apoptosis of human vascular endothelial cells and is involved in atherosclerosis. J Cell Physiol. https://doi.org/10.1002/jcp.29974
Gou S, Wang L, Zhong C, Chen X, Ouyang X, Li B, Bao G, Liu H, Zhang Y, Ni J (2020) A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE mice. Br J Pharmacol. https://doi.org/10.1111/bph.15213
Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O’Fallon WM, Whisnant JP, Wiebers DO, Seward JB (2002) Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 89(3):262–267. https://doi.org/10.1016/s0002-9149(01)02225-1
Folsom AR, Gottesman RF, Appiah D, Shahar E, Mosley TH (2016) Plasma d-dimer and incident ischemic stroke and coronary heart disease: the atherosclerosis risk in communities study. Stroke 47(1):18–23. https://doi.org/10.1161/STROKEAHA.115.011035
Riccioni G, Sblendorio V (2012) Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol 9(3):305–317. https://doi.org/10.3724/SP.J.1263.2012.02132
Niu L, Qian M, Yang W, Meng L, Xiao Y, Wong KK, Abbott D, Liu X, Zheng H (2013) Surface roughness detection of arteries via texture analysis of ultrasound images for early diagnosis of atherosclerosis. PLoS ONE 8(10):e76880. https://doi.org/10.1371/journal.pone.0076880
Betriu-Bars A, Fernandez-Giraldez E (2012) Carotid ultrasound for the early diagnosis of atherosclerosis in chronic kidney disease. Nefrologia 32(1):7–11. https://doi.org/10.3265/Nefrologia.pre2011.Dec.11258
Bennett MR, Sinha S, Owens GK (2016) Vascular smooth muscle cells in atherosclerosis. Circ Res 118(4):692–702. https://doi.org/10.1161/CIRCRESAHA.115.306361
He L, Gao J, Yu X, Wen F, Luo J, Qin Y, Chen M, Zhang D, Wang Z, Tang C (2020) Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2020.173408
Sun H, Wu S, Sun B (2020) MicroRNA-532-5p protects against atherosclerosis through inhibiting vascular smooth muscle cell proliferation and migration. Cardiovasc Diagn Ther 10(3):481–489. https://doi.org/10.21037/cdt-20-91
Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C (2011) MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109(8):880–893. https://doi.org/10.1161/CIRCRESAHA.111.240150
Clarke MC, Talib S, Figg NL, Bennett MR (2010) Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res 106(2):363–372. https://doi.org/10.1161/CIRCRESAHA.109.208389
Shi N, Chen SY (2014) Mechanisms simultaneously regulate smooth muscle proliferation and differentiation. J Biomed Res 28(1):40–46. https://doi.org/10.7555/JBR.28.20130130
Li H, Liu X, Zhang L, Li X (2017) LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway. Oncotarget 8(70):114568–114575. https://doi.org/10.18632/oncotarget.21603
Choe N, Kwon JS, Kim YS, Eom GH, Ahn YK, Baik YH, Park HY, Kook H (2015) The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Cell Signal 27(6):1056–1065. https://doi.org/10.1016/j.cellsig.2014.12.022
Shen Y, Xu J, Pan X, Zhang Y, Weng Y, Zhou D, He S (2020) LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis. Cell death disease 11(4):278. https://doi.org/10.1038/s41419-020-2485-1
Wang H, Wang F, Wang X, Wu X, Xu F, Wang K, Xiao M, Jin X (2019) Friend or foe: a cancer suppressor microRNA-34 potentially plays an adverse role in vascular diseases by regulating cell apoptosis and extracellular matrix degradation. Med Sci Mon 25:1952–1959. https://doi.org/10.12659/msm.915270
Somasundaram S, Forrest ME, Moinova H, Cohen A, Varadan V, LaFramboise T, Markowitz S, Khalil AM (2018) The DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA methylation in colon cancer. Clin Epigenetics 10(1):127. https://doi.org/10.1186/s13148-018-0555-3
Wang C, Zhao J, Nan X, Guo Z, Huang S, Wang X, Sun F, Ma S (2020) Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5. Mol Med 26(1):74. https://doi.org/10.1186/s10020-020-00200-3
Chistiakov DA, Orekhov AN, Bobryshev YV (2015) Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf) 214(1):33–50. https://doi.org/10.1111/apha.12466
Kake S, Kawaguchi H, Nagasato T, Yamada T, Ito T, Maruyama I, Miura N, Tanimoto A (2020) Association between HMGB1 and thrombogenesis in a hyperlipaemia-induced microminipig model of atherosclerosis. vivo 34(4):1871–1874. https://doi.org/10.21873/invivo.11982
Chen L-B, An Z, Zheng H-K, Wang X-P, Shan R-T, Mao C-Y, Zhang W-Q (2020) MicroRNA-34c suppresses proliferation of vascular smooth muscle cell via modulating high mobility group box protein 1. J Clin Lab Anal 34(7):e23293. https://doi.org/10.1002/jcla.23293
Rayapu L, Chakraborty K, Valluru L (2020) Marine algae as a potential source for anti-diabetic compounds - A brief review. Curr Pharm Des. https://doi.org/10.2174/1381612826666200909124526
Hu J, Hu X, Kan T (2019) MiR-34c participates in diabetic corneal neuropathy via regulation of autophagy. Invest Ophthalmol Vis Sci 60(1):16–25. https://doi.org/10.1167/iovs.18-24968
Wang S, Li Y, Liang Y, Dong J, He Y, Zhang L, Yan Y (2017) Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance. J Cell Mol Med 21(12):3372–3380. https://doi.org/10.1111/jcmm.13240
Baldeón RL, Weigelt K, de Wit H, Ozcan B, van Oudenaren A, Sempértegui F, Sijbrands E, Grosse L, van Zonneveld A, Drexhage H, Leenen P (2015) Type 2 diabetes monocyte microRNA and mRNA expression: dyslipidemia associates with increased differentiation-related genes but not inflammatory activation. PLoS ONE 10(6):e0129421. https://doi.org/10.1371/journal.pone.0129421
Funding
No funding.
Author information
Authors and Affiliations
Contributions
XJ and ZJL: literature research, experiment studies, research design, data analysis, and manuscript writing. XJQ: data analysis, experiment work, manuscript editing and clinical studies. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
General Hospital of Ningxia Medical University Ethics Committee approved this study (GHNMU2018050625532). All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jiang, X., Liu, Z. & Qi, X. LncRNA BANCR induced vascular smooth muscle cell proliferation by downregulating miR-34c methylation in atherosclerosis. J Thromb Thrombolysis 51, 924–932 (2021). https://doi.org/10.1007/s11239-020-02314-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-020-02314-1